286
Views
40
CrossRef citations to date
0
Altmetric
Esophagus

Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study

, , , , , , , , & show all
Pages 1429-1435 | Received 29 Jun 2012, Accepted 13 Sep 2012, Published online: 30 Oct 2012

References

  • Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastroesophageal junction. Lancet 1994;334:1533–6.
  • Meining A, Ott R, Becker I, Hahn S, Mühlen J, Werner M, The Munich Barrett follow-up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only- what is the clinical significance? Gut 2004;53:1402–7.
  • Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastrol 2007;101:1900–20.
  • Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004;53:1070–4.
  • Malfertheiner P, Lind T, Willich S, Vieth M, Jaspersen D, Labenz J, Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study. Gut 2005;54:746–51.
  • Labenz J, Nocon M, Lind T, Leodolter A, Jaspersen D, Meyer-Sabellek W, Prospective follow-up data from the ProGERD study suggest that GERD is not a categorical disease. Am J Gastroenterol 2006;101:2457–62.
  • Kulig M, Nocon M, Vieth M, Leodolter A, Jaspersen D, Labenz J, Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol 2004;57:580–9.
  • Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163–74.
  • Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005;129:1825–31.
  • Shaheen NJ, Peery AF, Overholt BF, Lightdale CJ, Chak A, Wang KK, Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus. Gastrointest Endosc 2010;72:490–6.
  • Takubo K, Vieth M, Aryal G, Honma N, Sawabe M, Arai T, Islands of squamous epithelium and their surrounding mucosa in columnar-lined esophagus: a pathognomonic feature of Barrett's esophagus? Hum Pathol 2005;36:269–74.
  • Guindi M, Riddell RH. Histology of Barrett's esophagus and dysplasia. Gastrointestin Endosc Clin N Am 2003;13:349–68.
  • Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005;129:1825–31.
  • Nocon M, Kulig M, Leodolter A, Malfertheiner P, Willich SN. Validation of the Reflux Disease Questionnaire for a German population. Eur J Gastroenterol Hepatol 2005;17:229–33.
  • Hanna S, Rastogi A, Weston AP, Totta F, Schmitz R, Mathur S, Detection of Barrett's esophagus after endoscopic healing of erosive esophagitis. Am J Gastroenterol 2006;101:1416–20.
  • Gilani N, Gerkin RD, Ramirez FC, Hakim S, Randolph AC. Prevalence of Barrett's esophagus in patients with moderate to severe esophagitis. World J Gastroenterol 2008;14:3518–22.
  • Leodolter A, Nocon M, Vieth M, Lind T, Jaspersen D, Malfetheiner P, Microscopic Barrett's esophagus (MBE) - an entity of concern in the ProGERD study. Gastroenterology 2008;134:A78–9.
  • Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Vieth M, Does microscopic Barrett's esophagus progress to Barrett's esophagus? Data from the population-based Kalixanda study. Gastroenterology 2008;134:A432.
  • Ronkainen J, Talley NJ, Storskrubb T, Johansson SE, Lind T, Vieth M, Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol 2011;106:1946–52.
  • El-Omar EM. The importance of interleukin 1 beta in Helicobacter pylori associated disease. Gut 2001;48:774–81.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.